Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EnBio Holdings's ROE % for the quarter that ended in Mar. 2026 was 14.60%. EnBio Holdings's PB Ratio for the quarter that ended in Mar. 2026 was 0.67.
EnBio Holdings's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 was 21.79%.
EnBio Holdings ROE % Adjusted to Book Value Related Terms
EnBio Holdings ROE % Adjusted to Book Value Historical Data
* Premium members only.
The historical data trend for EnBio Holdings's ROE % Adjusted to Book Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:6092 vs CTAS, CPRT, ULS: ROE % Adjusted to Book Value Comparison
For the Specialty Business Services subindustry, EnBio Holdings's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
EnBio Holdings ROE % Adjusted to Book Value vs Business Services Industry
For the Business Services industry and Industrials sector, EnBio Holdings's ROE % Adjusted to Book Value distribution charts can be found below:
* The bar in red indicates where EnBio Holdings's ROE % Adjusted to Book Value falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROE % Adjusted to Book Value of 21.79% mean?
EnBio Holdings (TSE:6092) has a ROE % Adjusted to Book Value of 21.79% as of Mar. 2026. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on EnBio Holdings and its competitors.
Is EnBio Holdings' ROE % Adjusted to Book Value too high?
EnBio Holdings' current ROE % Adjusted to Book Value is 21.79%. Overall, EnBio Holdings has a GF Score™ of 58/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does EnBio Holdings' ROE % Adjusted to Book Value compare to CTAS and CPRT?
EnBio Holdings' ROE % Adjusted to Book Value of 21.79% can be compared against companies in the Business Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Business Services company?
A good ROE % Adjusted to Book Value depends on the Business Services industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on EnBio Holdings and its competitors. EnBio Holdings's current ROE % Adjusted to Book Value is 21.79%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EnBio Holdings stock overvalued right now?
Based on GuruFocus' analysis, EnBio Holdings (TSE:6092) is currently considered Fairly Valued. The stock's GF Value™ is 円799.37, compared to a current price of 円728.00 — trading 8.9% below its estimated fair value. The current ROE % Adjusted to Book Value is 21.79%. EnBio Holdings' overall GF Score™ is 58/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For EnBio Holdings (TSE:6092), the current ROE % Adjusted to Book Value is 21.79% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is EnBio Holdings (TSE:6092) Overvalued in 2026?
Based on GuruFocus' analysis, EnBio Holdings stock appears to be undervalued.
The current stock price of 円728.00 is trading 8.9% below its estimated GF Value™ of 円799.37.
GuruFocus considers EnBio Holdings to be Fairly Valued.
Key valuation signals for TSE:6092:
ROE % Adjusted to Book Value: 21.79%
GF Value™: 円799.37 vs. price of 円728.00 (8.9% below fair value)
No single metric tells the full story. See the TSE:6092 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
EnBio Holdings Inc is a Japanese company engaged in environmental solution business, tools and chemicals business, and brownfield revitalization business. The environmental business involves investigation, remediation and risk management consulting of contaminated soil and groundwater; Tools and chemicals business involves sales of chemicals used for environmental work such as site investigation and remediation; and brownfield revitalization business which involves purchasing and regeneration of brownfields. The objective of the company is solving soil and groundwater contamination issues.
58GF Score
Get the complete analysis for TSE:6092
ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:6092 has been successfully added to your 
